Initially, Novo Nordisk pursued covering its flagship GLP-1 Wegovy under Medicaid in multiple states, arguing long-term cost savings from obesity reduction ( [33] )
However, links between TRT and prostate cancer remain inconclusive
Don't take all of them prophylacticallyadd them as specific needs emerge, and discontinue if symptoms resolve
But one researcher, John Cawley, a professor of economics and public policy at Cornell University, and his colleagues found that while obesity basically doubles a persons annual health care costs, the savings associated with public insurance plans covering GLP-1s for just obesity treatment are dependent on the patients body mass index, or BMI
To ensure proper covariate assessment, cohort members were required to have resided in Denmark for at least 12 months prior to initiating treatment